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Background: Keratoacanthoma is a relatively common low-grade malignancy that originates in the pilosebaceous
glands. Pathologically, it closely resembles squamous cell carcinoma. Keratoacanthoma is believed to have a good
prognosis; however, it has been reclassified as squamous cell carcinoma, keratoacanthoma type, to reflect the
difficulty in histologic differentiation of this lesion as well as its uncommon but potentially aggressive nature.
Keratoacanthoma infrequently presents as multiple tumors and may enlarge (5–15 cm), become locally aggressive,
and rarely metastasize.
Case presentation: A 66-year-old Arab male patient with diabetes was referred to the Maxillofacial Surgery Department
with a chief complaint of a dome-shaped nodule with a smooth, shiny surface and central crateriform ulceration with
a keratin plug in the form of a horn-like projection. Skin papules were present in the right lateral canthal area and
extended to the lateral border of the lower eyelid, measuring 1.3 cm. On palpation, the lesion was firm, movable, and
tender. The patient had a history of a similar lesion in another area of his face that had spontaneously regressed.
Conclusion: Histological differentiation between keratoacanthoma and well-differentiated squamous cell carcinoma is
difficult, particularly when a secondary infection is present. Careful establishment of the correlation among the history,
clinical findings, and histopathology is highly indicated to avoid unnecessary surgical intervention.
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Keratoacanthoma (KA) is a relatively common low-grade
malignancy that originates in the pilosebaceous glands.
Pathologically, it closely resembles squamous cell carcin-
oma (SCC). KA is characterized by rapid growth over a
few weeks to months, followed by spontaneous resolution
over 4 to 6 months in most cases. It is noninvasive and
does not metastasize. Both chemical carcinogens and sun-
light have been implicated as pathologic factors involved
in the growth of the tumor. Genetic factors, human papil-
loma virus, trauma, and an immunocompromised status
have also been implicated as etiologic factors [1-6]. Similar
epidemiological features between KA and conventional
SCC suggest a possible common pathogenesis, such as
actinic damage [7]. KA and SCC have comparable inci-
dences [7]. After the age of 64 years, the incidences of
both KA and SCC increase significantly. The average pa-
tient age at the time of lesion development is 67 years forCorrespondence: esamomar@hotmail.com
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unless otherwise stated.KA and 66 years for SCC. The male:female ratio for
both conditions is similar at 2:1 [7]. Chuang et al., [8] and
Reizner et al., [9] reported that the incidence of KA is
equal to that of SCC and challenged the commonly re-
ported KA:SCC incidence ratio of 1:3. The peak incidence
occurs in the seventh decade or beyond. In other studies,
the ratio of KA to SCC has ranged from 1.0:0.6 to 1:5 in
different geographic locations [8,9]. KA is uncommon in
darker-skinned patients. Approximately one-fifth to one-
sixteenth of cases affect American whites [8,9]. Differ-
entiation of KA from well-differentiated SCC may be
problematic. The malignancy, however, lacks the character-
istic acute angle between the normal and lesional epithelial
margins of the KA, and both benign entities demonstrate
a “pushing” extension into the underlying stroma with
none of the characteristic invading islands and individual
dysplastic cells of the carcinoma.
Case presentation
A 66-year-old Arab male patient with diabetes was re-
ferred to the Maxillofacial Surgery Department with ais is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Photograph of the lesion before surgical excision. The
lesion was a dome-shaped nodule with smooth, shiny surface and
central crateriform ulceration with a keratin plug in the form of a
horn-like projection. Skin papules were present in the right lateral
canthal area (lower eyelid).
Figure 2 Photograph of the wound after surgical excision. A safe
margin of 3 mm was established with preservation of the lateral
canthal ligament and lower eyelid volume.
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shiny surface and a central crateriform ulceration with
a keratin plug in the form of a horn-like projection.
Skin papules were present in the right lateral canthal
area and extended to the lateral border of the lower
eyelid, measuring 1.3 cm. On palpation, the lesion was
firm, movable, and tender. It was secondarily infected
and had a history of rapid progression over the last
5 weeks.
The patient had a history of the same lesion at the ver-
million border of the lower lip that was diagnosed as
SCC at another medical center 6 years previously. The
SCC was surgically treated by a V-wedge resection of the
lower lip at that time. One and a half years later, the same
lesion reappeared in the left lateral canthal area and ex-
tended over the lower eyelid. The patient did not seek
medical treatment. He claimed that the psychological
impact of the lip resection prevented him from seek-
ing medical treatment. The patient stated that this lesion
spontaneously disappeared after 5 months. One year later,
a similar lesion reappeared on the right nasolabial fold
and soon disappeared within a few weeks.
At the present presentation, the same lesion was ob-
served in the right canthal area, extending to the lower
eyelid. The patient was now seeking treatment because
of pain secondary to infection of the lesion. The prelim-
inary diagnosis of the lesion was a secondarily infected
KA, and the differential diagnoses included SCC, verru-
cous carcinoma, and metastatic skin carcinoma.
A clinical decision was made to approach the case surgi-
cally. Ectropion was considered as a possible postoperative
complication. Excisional biopsy was performed under
local anesthesia with 2% lidocaine and 1:100,000 epineph-
rine. The infraorbital and zygomaticofacial nerves were
anesthetized. The patient was informed about all possible
complications and provided written consent to undergo
simple surgical excision and primary closure without the
use of a local flap. A simple elliptical incision was created
with a 3-mm safe margin, and local tissues were bilaterally
advanced for closure [Figures 1 and 2]. The wound was
closed primarily using Vicryl 4–0, and postoperative
prophylactic antibiotic and analgesic medications were
prescribed. The patient underwent suture removal 7 days
later, and no complications were observed.
Histopathological examination of the biopsy specimen
showed well-differentiated squamous epithelium with only
a mild degree of pleomorphism from the basal layer to the
surface keratin. However, dyskeratosis (abnormal or pre-
mature keratin production) was present as evidenced by
individually keratinizing lesional cells and keratin pearls
identical to those of well-differentiated SCC.
The correlation among the history, clinical picture, and
histopathological findings strongly suggested KA. The pa-
tient was followed up for 6 months without recurrence.Conclusions
Ideal treatment of KA involves surgical resection with a
safe margin of 3 to 5 mm. Medical treatment can be
used for patients in whom surgical intervention is either
not feasible or desirable for anatomical reasons or be-
cause of the patient’s systemic condition. Medical interven-
tion may be appropriate in patients with multiple lesions,
patients with lesions not amenable to surgery because of
the lesion size or location, and patients with comorbidities
that contraindicate the performance of a surgical proced-
ure. The literature concerning medical intervention for KA
is limited to case reports and of unproved. Systemic reti-
noids, such as isotretinoin, may be considered for patients
with lesions too numerous for surgical intervention. Intrale-
sional methotrexate [10], 5-fluorouracil, bleomycin, and
steroids have been used with success [11]. Annest in 2002
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in 38 patients, 18 of whom showed a 92% rate of clinical
resolution; however, the patients needed an average of
two injections [10]. Dendorfer in 2003 used both top-
ical imiquimod and 5-fluorouracil and achieved complete
remission in 4 to 11 weeks [12]. KA is radiosensitive and
responds well to low doses of radiation (< 10 Gy). Radi-
ation therapy may be useful in select patients with large
tumors in whom resection will result in a cosmetic de-
formity or in patients with tumors that have recurred
following excisional surgery. Radiation therapy is less
appealing in younger patients, in whom radiation damage
worsens with time. Radiation therapy is an important alter-
native treatment for select patients who understand its risks
and benefits and who are not good surgical candidates [13].
Both laser therapy and cryotherapy have been used success-
fully in patients with small KAs, in patients with KAs in lo-
cations difficult to treat surgically, and as an adjunct to
surgical removal. The primary therapy for KA is currently
surgical excision with adequate margins (3–5 mm) and
histopathologic evaluation to exclude invasive SCC. A par-
tial shave biopsy usually inadequately distinguishes KA
from invasive SCC. Because the biological behavior of an
individual KA cannot be predicted, many consider surgical
treatment of KA to be equivalent to treatment for SCC.
Mohs micrographic surgery may be indicated for large or
recurrent KAs or for KAs located in anatomic areas with
cosmetic or functional considerations.
The differentiation between KA and well-differentiated
SCC may be problematic, particularly in cases of second-
arily infected KAs, in which the histopathological picture
may appear to be more aggressive in nature than is the
actual KA. In such cases, the findings of the histopatho-
logical study, which is one of the most reliable diagnostic
techniques, may direct the treatment of KA toward an
unnecessary surgical procedure. Therefore, careful estab-
lishment of the correlation among the history, clinical
findings, and histopathological picture is highly indicated
in patients with KA, particularly in those with secondar-
ily infected KAs, which may have lost the typical clinical
characteristics of uninfected KAs. This is recommended
to avoid unneeded major surgical intervention, possible
surgical complications, and high costs.
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